4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-004866
Interim CEO & General Counsel gave up 6,530 shares (to pay taxes)
- Interim CEO & General Counsel acquired 20,834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-01-16 | Option exercise | +20,834 | 105,668 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2024-01-16 | Shares withheld for taxes | −6,530 | $8.37 | $54,656 | 99,138 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2024-01-16 | Option exercise · Restricted Stock Units | −20,834 | 83,338 | D: show line 3 in the form |
Loading xslF345X05/tm243610-3_4seq1.xml…